Ticker | Company name | Industry | Market Cap in Bln |
Dividend Yield | Dividend Frequency | Stock price | Currency | Stock Exchange |
---|---|---|---|---|---|---|---|---|
FRE | Fresenius SE | Healthcare | 21.42 | 2.19 % | Annual | 38.43 | EUR | Deutsche Borse Frankfurt |
Company's Past Performance











The 5 years average P/E ratio is the average of each year’s P/E ratios. P/E ratio in any year is limited to 30 in order to reduce the effect of the extreme values on the average P/E.
Company Profile
Fresenius SE & Co. KGaA engages in the provision of healthcare related products and services. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment provides dialysis products and services. The Fresenius Kabi segment specializes in intravenously administered generic drugs, clinical nutrition, and infusion therapies. The Fresenius Helios segment operates acute and maximum care hospitals as well as post-acute care clinics. The Fresenius Vamed segment manages projects and offers services for hospitals and other healthcare facilities. The Corporate and Other segment comprises the holding activities of the company and the information technology service provider Fresenius Netcare. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.